Stay updated on ADXS-NEO Personalized Tumor Antigens Clinical Trial
Sign up to get notified when there's something new on the ADXS-NEO Personalized Tumor Antigens Clinical Trial page.

Latest updates to the ADXS-NEO Personalized Tumor Antigens Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays Revision: v3.4.2 and the prior funding/operating status notice was removed, reflecting a site maintenance update rather than a change to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding lapse notice with operating status and updated site revision to v3.4.1; the previous revision label v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedUI/metadata updates including a glossary toggle, a new revision label (v3.4.0), and added/updated fields such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'; corresponding older text variants were removed or adjusted.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision history updated: added Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a centralized Locations section listing Arizona, California, Louisiana, and New Jersey; removed individual state location pages and the HHS Vulnerability Disclosure link, updating to Revision: v3.3.3.SummaryDifference0.5%

- Check91 days agoChange DetectedPublications section wording updated to 'results of the study' and revision tag updated from v3.2.0 to v3.3.2; this is a minor editorial change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ADXS-NEO Personalized Tumor Antigens Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADXS-NEO Personalized Tumor Antigens Clinical Trial page.